FDA Inspection 755958 — Sentry Biopharma Services, Inc.

Sentry Biopharma Services, Inc. — FEI 3007066137

The FDA completed an inspection of Sentry Biopharma Services, Inc. on December 6, 2011 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 6, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)